InvestorsHub Logo
Followers 27
Posts 2738
Boards Moderated 0
Alias Born 06/28/2011

Re: None

Monday, 07/28/2014 10:04:57 AM

Monday, July 28, 2014 10:04:57 AM

Post# of 104401

THE PROBLEM

To achieve efficient healthcare in an increasingly demanding marketplace, the ability to get actionable information is crucial. Medical diagnostic assays currently count in the multi-millions per year and per country, and differences in tissues types at the cellular level are critically important for accuracy in results. Conventional organic dyes and other types of fluorophores are currently used for luminescence in assays by researchers, but they have limitations sometimes preventing clear distinctions in reading the data. Broad data sets can tend to obscure patterns that might become clear by removing these uncertainties.

Blood assays to determine medical conditions and diseases are typically collected and sent to a local lab and placed in an array for analysis. Turn-around time for taking the sample, transporting, conducting the analysis, and responding to the patient’s doctor can take days to weeks. A new method that Doctors can use in their office during an appointment to facilitate ordering treatments if necessary would require a test format that can be accomplished simply and relatively instantaneously, and with the highest levels of accuracy.
http://www.qmcdots.com/products/products-nanobio.php

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.